TEVA – teva pharmaceutical industries limited american depositary shares (US:NASDAQ)
Stock Stats
News
3/19
08:07 pm
teva
Neutral
Sacklers to pay up to $7bn in Purdue Pharma's opioid settlement plan [Yahoo! Finance]
3/14
03:27 am
teva
Low
Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma
3/13
11:58 am
teva
Low
Lumicera Secures Purchase Agreement for Stelara® Biosimilar, Delivering Major Cost Savings [Yahoo! Finance]
3/7
11:03 pm
teva
Medium
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/6
10:41 am
teva
Low
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target lowered by analysts at Bank of America Co. from $23.00 to $20.00. They now have a "buy" rating on the stock.
1/29/2025
07:00 am
TEVA
-14.1%
BEAT
1/29/2025
07:00 am
TEVA
-7.2%
BEAT
1/29/2025
07:00 am
TEVA
-8.1%
BEAT
1/29/2025
07:00 am
TEVA
-9.4%
BEAT
1/30
06:24 pm
Maintains
Buy
Buy
UBS
Low
-0.6%
1/30
06:51 am
Maintains
Overweight
Overweight
Barclays
Medium
-4.3%
1/30
06:51 am
Maintains
Overweight
Overweight
Barclays
Medium
-4.3%
1/23
08:57 am
Maintains
Buy
Buy
UBS
Low
-0.5%
3/7
04:29 pm
teva
Medium
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Weiss Amir
3/7
04:25 pm
teva
Medium
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Fox Christine
3/7
04:23 pm
teva
Medium
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: McAvoy David R.
3/7
04:19 pm
teva
Medium
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Kalif Eliyahu Sharon
3/7
04:17 pm
teva
Medium
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Hughes Eric A
Show more
Top News Gainers
10/18 Shortage of critical children’s cancer drug causes concerns nationwide [MSNBC.com] 16.9%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
Top News Decliners
5/11 U.S. states sue Teva, 19 other drug companies in price-fixing complaint [Reuters (UK)] -14.7%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3